Kevin Tang

Insider Reports History

Entity: Individual
Location: 4747 Executive Drive, Suite 210, San Diego, CA
Signature: Kevin Tang
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Tang:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Aurinia Pharmaceuticals Inc.	Director	Common Shares	10M	$81.1M	$8.09	Mar 4, 2025	By LP
Odonate Therapeutics, Inc.	Chief Executive Officer, Director, 10%+ Owner	Common Stock	12.8M	$20M	$1.57	Nov 19, 2021	By LP
Jounce Therapeutics, Inc.	Director, 10%+ Owner	Common Stock	10K	$18.5K	$1.85	May 3, 2023	By LP
Rain Oncology Inc.	10%+ Owner	Common Stock	0	$0	$1.21	Jan 26, 2024	By LP
Singular Genomics Systems, Inc.	10%+ Owner	Common Stock	0	$0	$19.89	Feb 21, 2025	By LP
TCR2 THERAPEUTICS INC.	10%+ Owner	Common Stock	0	$0	$1.72	Jun 1, 2023	By LP
Aptevo Therapeutics Inc.	Exit Filing	Common Stock	0			Nov 23, 2021	By LP
LA JOLLA PHARMACEUTICAL CO	Director, 10%+ Owner	Common Stock	0		$6.23	Aug 22, 2022	BY LP
LA JOLLA PHARMACEUTICAL CO	Director, 10%+ Owner	Series C-1(2) Convertible Preferred Stock	0			Aug 22, 2022	BY LP
LA JOLLA PHARMACEUTICAL CO	Director, 10%+ Owner	Stock Option (Right to Buy)	0			Aug 22, 2022	Direct

Previous1Next

Showing 1 to 10 of 10 entries

Insider Reports Filed by Kevin Tang

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
AUPH	Aurinia Pharmaceuticals Inc.	Feb 28, 2025	6	$12.7M	4	Mar 4, 2025	Director
OMIC	Singular Genomics Systems, Inc.	Feb 21, 2025	1	$0	4	Feb 27, 2025	10%+ Owner
AUPH	Aurinia Pharmaceuticals Inc.	Dec 5, 2024	3	$10.8M	4	Dec 9, 2024	Director
OMIC	Singular Genomics Systems, Inc.	Sep 16, 2024	3	$1.81M	4	Sep 18, 2024	10%+ Owner
OMIC	Singular Genomics Systems, Inc.	Sep 16, 2024	0	$0	3	Sep 18, 2024	10%+ Owner
AUPH	Aurinia Pharmaceuticals Inc.	Sep 12, 2024	0	$0	3	Sep 23, 2024	Director
RAIN	Rain Oncology Inc.	Jan 26, 2024	1	$0	4	Feb 2, 2024	10%+ Owner
RAIN	Rain Oncology Inc.	Dec 14, 2023	3	-$209K	4	Dec 18, 2023	10%+ Owner
RAIN	Rain Oncology Inc.	Oct 11, 2023	5	$279K	4	Oct 13, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	Jun 1, 2023	1	$0	4	Feb 14, 2024	10%+ Owner
RAIN	Rain Oncology Inc.	May 30, 2023	9	$1.16M	4	Jun 1, 2023	10%+ Owner
RAIN	Rain Oncology Inc.	May 30, 2023	0	$0	3	Jun 1, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	May 25, 2023	1	$86K	4	May 30, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	May 11, 2023	2	$87.6K	4	May 15, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	May 8, 2023	3	$164K	4	May 10, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	May 3, 2023	4	$548K	4	May 5, 2023	10%+ Owner
TCRR	TCR2 THERAPEUTICS INC.	May 3, 2023	0	$0	3	May 5, 2023	10%+ Owner
JNCE	Jounce Therapeutics, Inc.	May 3, 2023	2	$87.6M	4	May 5, 2023	Director, 10%+ Owner
JNCE	Jounce Therapeutics, Inc.	Mar 13, 2023	2	$86K	4	Mar 14, 2023	10%+ Owner
JNCE	Jounce Therapeutics, Inc.	Mar 13, 2023	0	$0	3	Mar 14, 2023	10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	Aug 22, 2022	11	-$59.9M	4	Aug 24, 2022	Director, 10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	Aug 22, 2022	2	-$59.9M	4	Aug 24, 2022	Director, 10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	Jan 12, 2022	1	$0	4	Jan 14, 2022	Director, 10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	Nov 29, 2021	5	-$1.73M	4	Dec 1, 2021	Director, 10%+ Owner
APVO	Aptevo Therapeutics Inc.	Nov 23, 2021	7	-$10.4M	4	Nov 26, 2021	Exit Filing
APVO	Aptevo Therapeutics Inc.	Nov 18, 2021	10	-$6.5M	4	Nov 22, 2021	10%+ Owner
ODT	Odonate Therapeutics, Inc.	Nov 17, 2021	8	-$5.73M	4	Nov 19, 2021	Chief Executive Officer, Director, 10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	May 27, 2021	4	$1.1M	4	Jun 1, 2021	Director, 10%+ Owner
LJPC	LA JOLLA PHARMACEUTICAL CO	May 24, 2021	4	$1.58M	4	May 26, 2021	Director, 10%+ Owner